Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases

Vadas, Oscar, Burke, John E., Zhang, Xuxiao, Berndt, Alex, Williams, Roger L.·2011·Science Signaling

Cited by (299)

Items 101–200 of 299

  1. Inositol phosphate kinases: Expanding the biological significance of the universal core of the protein kinase fold
    Stephen B. Shears, Huanchen Wang · 2018 · Advances in Biological Regulation
  2. NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation
    Amit Bera, Nandini Ghosh‐Choudhury, Nirmalya Dey, Falguni Das, Balakuntalam S. Kasinath, Hanna E. Abboud, Goutam Ghosh Choudhury · 2013 · Cellular Signalling
  3. Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention
    Ruth Nussinov, Mingzhen Zhang, Chung‐Jung Tsai, Tsung-Jen Liao, David Fushman, Hyunbum Jang · 2018 · Biophysical Reviews
  4. Phosphorylation and Driver Mutations in PI3Kα and PTEN Autoinhibition
    Ruth Nussinov, Mingzhen Zhang, Chung‐Jung Tsai, Hyunbum Jang · 2020 · Molecular Cancer Research
  5. Structural Features that Distinguish Inactive and Active PI3K Lipid Kinases
    Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov · 2020 · Journal of Molecular Biology
  6. Regulation of G Protein βγ Signaling
    Kanishka Senarath, Dinesh Kankanamge, Saroopa P. Samaradivakara, Kasun Ratnayake, Mithila Tennakoon, Ajith Karunarathne · 2018 · International review of cytology
  7. The Role of Phosphatidylinositol Phosphate Kinases during Viral Infection
    Anne Beziau, Denys Brand, Éric Piver · 2020 · Viruses
  8. Type III phosphatidylinositol 4 kinases: structure, function, regulation, signalling and involvement in disease
    Gillian L. Dornan, Jacob Alec McPhail, John E. Burke · 2016 · Biochemical Society Transactions
  9. PI3K Driver Mutations: A Biophysical Membrane-Centric Perspective
    Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov · 2020 · Cancer Research
  10. NSAID therapy for PIK3CA-Altered colorectal, breast, and head and neck cancer
    Yi Cai, Andrew Yousef, Jennifer Rubin Grandis, Daniel E. Johnson · 2019 · Advances in Biological Regulation
  11. Biochemical, biological and structural properties of romidepsin ( FK 228) and its analogs as novel HDAC / PI 3K dual inhibitors
    Ken Saijo, Jin Imamura, Kôichi Narita, Akifumi Oda, Hideki Shimodaira, Tadashi Katoh, Chikashi Ishioka · 2014 · Cancer Science
  12. Data-Driven Modeling for Precision Medicine in Pediatric Acute Liver Failure
    Rubén Zamora, Yoram Vodovotz B, Qi Mi, Derek A. Barclay, Jinling Yin, Simon Peter Horslen, David A. Rudnick, Kathleen M. Loomes, Robert H. Squires · 2016 · Molecular Medicine
  13. Probing the Architecture, Dynamics, and Inhibition of the PI4KIIIα/TTC7/FAM126 Complex
    Gillian L. Dornan, Udit Dalwadi, David J. Hamelin, Reece M. Hoffmann, Calvin K. Yip, John E. Burke · 2018 · Journal of Molecular Biology
  14. Oncogenic mutations weaken the interactions that stabilize the p110α‐p85α heterodimer in phosphatidylinositol 3‐kinase α
    Ignacia Echeverria, Yunlong Liu, Sandra B. Gabelli, L. Mario Amzel · 2015 · FEBS Journal
  15. Autoinhibition and Phosphorylation-Induced Activation of Phospholipase C-γ Isozymes
    Nicole Hajicek, Thomas H. Charpentier, Jeremy R. Rush, T. Kendall Harden, John Sondek · 2013 · Biochemistry
  16. A brief guide to good practices in pharmacological experiments: Western blotting
    Lu Tie, Han Xiao, Dalei Wu, Ye Yang, Pei Wang · 2020 · Acta Pharmacologica Sinica
  17. Phosphatidylinositol Kinases and Phosphatases in Entamoeba histolytica
    Kumiko Nakada‐Tsukui, Natsuki Watanabe, Tomohiko Maehama, Tomoyoshi Nozaki · 2019 · Frontiers in Cellular and Infection Microbiology
  18. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B
    Xinyi Li, Jinyuan Dai, Duan Ni, Xinheng He, Hao Zhang, Jian Zhang, Qiang Fu, Yaqin Liu, Shaoyong Lu · 2019 · International Journal of Biological Macromolecules
  19. Rare deleterious mutations of the gene EFR3A in autism spectrum disorders
    Abha R. Gupta, Michelle Pirruccello, Feng Cheng, Hyo Kang, Thomas V. Fernandez, Jeremy M. Baskin, Murim Choi, Li Liu, A. Gulhan Ercan‐Sencicek, John D. Murdoch et al. · 2014 · Molecular Autism
  20. Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-Kinases
    Gillian L. Dornan, Jordan TB Stariha, Manoj Kumar Rathinaswamy, Cameron J. Powell, Martin J. Boulanger, John E. Burke · 2019 · Structure
  21. Leptin and chronic kidney diseases
    Song Mao, Fang Li, Fen Liu, Siqiong Jiang, Liangxia Wu, Jianhua Zhang · 2018 · Journal of Receptors and Signal Transduction
  22. Induction of ligand promiscuity of αVβ3 integrin by mechanical force
    Michael Bachmann, Markus Schäfer, Vasyl V. Mykuliak, Marta Ripamonti, Lia Heiser, Kai Weißenbruch, Sarah Krübel, Clemens M. Franz, Vesa Pekka Hytönen, Bernhard Wehrle‐Haller et al. · 2020 · Journal of Cell Science
  23. Selective Inactivation of PTEN in Smooth Muscle Cells Synergizes With Hypoxia to Induce Severe Pulmonary Hypertension
    Henrick N. Horita, Seth B. Furgeson, Allison C. Ostriker, Kyle A. Olszewski, Timothy Sullivan, Leah R. Villegas, Michelle Levine, Jane E. Parr, Carlyne D. Cool, Raphael A. Nemenoff et al. · 2013 · Journal of the American Heart Association
  24. Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β
    Karla Salgado-Puga, Javier Rodríguez-Colorado, Roberto Agustín Prado-Alcalá, Fernando Peña‐Ortega · 2017 · Journal of Alzheimer s Disease
  25. Structural insights into isoform-specific RAS-PI3Kα interactions and the role of RAS in PI3Kα activation
    Daniel J. Czyzyk, Wupeng Yan, Simon A. J. Messing, William Gillette, Takashi Tsuji, Mitsuhiro Yamaguchi, Shinji Furuzono, David M. Turner, Dominic Esposito, Dwight V. Nissley et al. · 2025 · Nature Communications
  26. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR
    Shuai Zhao, Yang Cao, Shibo Liu, Xu-an Wang, Runfa Bao, Yijun Shu, Yunping Hu, Yi‐Jian Zhang, Lin Jiang, Fei Zhang et al. · 2016 · Journal of Experimental & Clinical Cancer Research
  27. Assembly of Membrane-Bound Protein Complexes: Detection and Analysis by Single Molecule Diffusion
    Brian P. Ziemba, Jefferson D. Knight, Joseph J. Falke · 2012 · Biochemistry
  28. Quantitative Phosphoproteomic Analysis Identifies Activation of the RET and IGF-1R/IR Signaling Pathways in Neuroblastoma
    Bradley D. DeNardo, Michael P. Holloway, Qinqin Ji, Kevin Tri Nguyen, Yan Cheng, Marcus B. Valentine, Arthur R. Salomon, Rachel A. Altura · 2013 · PLoS ONE
  29. Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer
    Yujun Hao, Baoyu He, Liping Wu, Yamu Li, Chao Wang, Ting Wang, Longci Sun, Yanhua Zhang, Yangyang Zhan, Yiqing Zhao et al. · 2022 · Nature Communications
  30. Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216
    Marlena Walls, Sangita M. Baxi, Pramod P. Mehta, Kevin K.‐C. Liu, JinJiang Zhu, Heather Estrella, Chunze Li, Michael A. Zientek, Qing Zong, Tod Smeal et al. · 2013 · Clinical Cancer Research · Retracted
  31. Signal Transduction: From the Atomic Age to the Post-Genomic Era
    Jeremy W. Thorner, Tony Hunter, Lewis C. Cantley, Richard Sever · 2014 · Cold Spring Harbor Perspectives in Biology
  32. HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural studies of class IB phosphoinositide 3-kinases
    Manoj Kumar Rathinaswamy, Kaelin D. Fleming, Udit Dalwadi, Els Pardon, Noah J Harris, Calvin K. Yip, Jan Steyaert, John E. Burke · 2021 · Structure
  33. Signaling Pathways in Leukemic Stem Cells
    Lindsay Meg Gurska, Kristina T. Ames, Kira Gritsman · 2019 · Advances in experimental medicine and biology
  34. Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
    Chie Ito, Satoshi Nishizuka, Kazuyuki Ishida, Noriyuki Uesugi, Tamotsu Sugai, Gen Tamura, Keisuke Koeda, Akira Sasaki · 2017 · Journal of Surgical Research
  35. Cytokine Receptor Endocytosis: New Kinase Activity-Dependent and -Independent Roles of PI3K
    Ping‐Hung Chen, Huiyu Yao, Lily Jun-shen Huang · 2017 · Frontiers in Endocrinology
  36. Upstream regulators of phosphoinositide 3‐kinase and their role in diseases
    Dandan Wang, Weijie Zhou, Jingyu Chen, Wei Wei · 2019 · Journal of Cellular Physiology
  37. Activation of innate immunity by mitochondrial dsRNA in mouse cells lacking p53 protein
    Dagmara Marta Wiatrek, Maria Elena Candela, Jiří Sedmík, Jan Oppelt, Liam P. Keegan, Mary A. O’Connell · 2019 · RNA
  38. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
    Ruth Nussinov, Serena Muratcioğlu, Chung‐Jung Tsai, Hyunbum Jang, Attila Gürsoy, Özlem Keskin · 2015 · Expert Opinion on Therapeutic Targets
  39. Engineering of an isolated p110α subunit of PI3Kα permits crystallization and provides a platform for structure‐based drug design
    Ping Chen, Ya‐Li Deng, Simon Bergqvist, Matthew D. Falk, Wei Liu, Sergei L. Timofeevski, Alexei Brooun · 2014 · Protein Science
  40. EnGens: a computational framework for generation and analysis of representative protein conformational ensembles
    Conev, Anja, Rigo, Mauricio Menegatti, Devaurs, Didier, Fonseca, André Faustino, Kalavadwala, Hussain, de Freitas, Martiela Vaz, Clementi, Cecilia, Zanatta, Geancarlo, Antunes, Dinler Amaral, Kavraki, Lydia E · 2023 · Briefings in Bioinformatics
  41. Okra polysaccharides can reverse the metabolic disorder induced by high-fat diet and cognitive function injury in Aβ1–42 mice
    Tingxu Yan, Tingting Nian, Bo Wu, Feng Xiao, Bosai He, Kaishun Bi, Ying Jia · 2019 · Experimental Gerontology
  42. Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections
    Jacob Alec McPhail, John E. Burke · 2020 · Advances in experimental medicine and biology
  43. The molecular mechanisms mediating class II PI 3‐kinase function in cell physiology
    Philipp Alexander Koch, Gillian L. Dornan, Manuel Hessenberger, Volker Haucke · 2021 · FEBS Journal
  44. Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus
    Yochai Birnbaum, Alexander Chase Castillo, Jinqiao Qian, Shukuan Ling, Hongmei Ye, Jose R. Perez-Polo, Mandeep Bajaj, Yumei Ye · 2012 · Cardiovascular Drugs and Therapy
  45. Interplay between phosphoinositide lipids and calcium signals at the leading edge of chemotaxing ameboid cells
    Joseph J. Falke, Brian P. Ziemba · 2014 · Chemistry and Physics of Lipids
  46. Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes
    Yumei Ye, Jinqiao Qian, Alexander Chase Castillo, Shukuan Ling, Hongmei Ye, Jose R. Perez-Polo, Mandeep Bajaj, Yochai Birnbaum · 2012 · American Journal of Physiology-Heart and Circulatory Physiology
  47. Lycium Barbarum Polysaccharides Improves Cognitive Functions in ICV-STZ-Induced Alzheimer’s Disease Mice Model by Improving the Synaptic Structural Plasticity and Regulating IRS1/PI3K/AKT Signaling Pathway
    Yingxi He, Yanyou Wang, Xia Li, Yanqiang Qi, Zuwei Qu, Yanli Hu · 2024 · NeuroMolecular Medicine
  48. PI3K inhibitors as novel cancer therapies: implications for cardiovascular medicine.
    Brent A. McLean, P. Zhabyeyev, E. Pituskin, I. Paterson, M. Haykowsky, Gavin Y. Oudit · 2013 · Journal of Cardiac Failure
  49. Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β
    Yoshihiro Ito, Peter K. Vogt, Jonathan Ross Hart · 2017 · Oncotarget
  50. PI3K and AKT at the Interface of Signaling and Metabolism
    Giovanni Solinas, Barbara Becattini · 2022 · Current topics in microbiology and immunology
  51. Discovery of a Small Molecule Agonist of Phosphatidylinositol 3-Kinase p110α That Reactivates Latent HIV-1
    Geneviève Doyon, Michele D. Sobolewski, Kelly D. Huber, Deborah K. McMahon, John W. Mellors, Nicolas Sluis‐Cremer · 2014 · PLoS ONE
  52. High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia
    Louise Kristensen, Thomas Kielsgaard Kristensen, Niels Abildgaard, Mads Thomassen, Mikael Frederiksen, Torben Mourits‐Andersen, Michael Boe Møller · 2015 · Leukemia Research
  53. Small Molecule Gated Split-Tyrosine Phosphatases and Orthogonal Split-Tyrosine Kinases
    Karla Camacho-Soto, Javier Castillo‐Montoya, Blake Tye, Luca O. Ogunleye, Indraneel Ghosh · 2014 · Journal of the American Chemical Society
  54. Isoform-selective targeting of PI3K: time to consider new opportunities?
    Davide Cirillo, Marta Diceglie, Marc Nazaré · 2023 · Trends in Pharmacological Sciences
  55. The G-Protein Rab5A Activates VPS34 Complex II, a Class III PI3K, by a Dual Regulatory Mechanism
    Thomas C. Buckles, Yohei Ohashi, Shirley Tremel, Stephen H. McLaughlin, Els Pardon, Jan Steyaert, Moshe T. Gordon, Roger L. Williams, Joseph J. Falke · 2020 · Biophysical Journal
  56. The ‘New (Nu)-clear’ evidence of the tumor-driving role of PI3K
    Franklin Mayca Pozo, Tony Hunter, Youwei Zhang · 2022 · Acta Materia Medica
  57. PI 3K‐dependent multiple myeloma cell survival is mediated by the PIK 3 CA isoform
    Claudia Hofmann, Thorsten Stühmer, Nadine Schmiedl, Reinhard Wetzker, Anja Mottok, Andreas Rosenwald, Christian Langer, Josip Zovko, Manik Chatterjee, Hermann Einsele et al. · 2014 · British Journal of Haematology
  58. Perturbations of PIP3 signalling trigger a global remodelling of mRNA landscape and reveal a transcriptional feedback loop
    Vladimir Yu Kiselev, Véronique Juvin, Mouhannad Malek, Nicholas M. Luscombe, Phillip T. Hawkins, Nicolas Gambardella Le Novère, Len Stephens · 2015 · Nucleic Acids Research
  59. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit
    Marey Shriver, Saravanakumar Marimuthu, Colin D. Paul, Janelle Geist, Tessa S. Seale, Κωνσταντίνος Κωνσταντόπουλος, Aikaterini Kontrogianni‐Konstantopoulos · 2016 · Oncotarget
  60. Chronic Unpredictable Mild Stress Aggravates Mood Disorder, Cognitive Impairment, and Brain Insulin Resistance in Diabetic Rat
    Hui Yang, Wei Li, Pan Meng, Zhuo Liu, Jian Liu, Yuhong Wang · 2018 · Evidence-based Complementary and Alternative Medicine
  61. A p85 isoform switch enhances PI3K activation on endosomes by a MAP4- and PI3P-dependent mechanism
    Narendra Thapa, Mo Chen, Vincent L. Cryns, Richard Anderson · 2024 · Cell Reports
  62. Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases – potentially novel therapeutic targets
    Yoshihiro Ito, Jonathan Ross Hart, Peter K. Vogt · 2018 · Expert Opinion on Therapeutic Targets
  63. Cardiovascular toxicity of PI3Kα inhibitors
    Chandu Sadasivan, Pavel Zhabyeyev, Dina Labib, James A. White, D. Ian Paterson, Gavin Y. Oudit · 2020 · Clinical Science
  64. Essential Role of Ubiquitin-Fold Modifier 1 Conjugation in DNA Damage Response
    Zhi Hong Fang, Zezheng Pan · 2019 · DNA and Cell Biology
  65. Allosteric Activation of PI3Kα Results in Dynamic Access to Catalytically Competent Conformations
    Mayukh Chakrabarti, Sandra B. Gabelli, L. Mario Amzel · 2020 · Structure
  66. Membrane Docking Geometry of GRP1 PH Domain Bound to a Target Lipid Bilayer: An EPR Site-Directed Spin-Labeling and Relaxation Study
    Huai-Chun Chen, Brian P. Ziemba, Kyle E. Landgraf, John Corbin, Joseph J. Falke · 2012 · PLoS ONE
  67. Cyclooxygenase-2 Deficiency in Macrophages Leads to Defective p110γ PI3K Signaling and Impairs Cell Adhesion and Migration
    Manuel D. Díaz‐Muñoz, Inés C. Osma-García, Miguel Angel Iñiguez, Manuel Fresno · 2013 · The Journal of Immunology
  68. Gβγ interacts with mTOR and promotes its activation
    Evelyn Robles‐Molina, Misael Neri Dionisio-Vicuña, María Luisa Guzmán-Hernández, Guadalupe Reyes‐Cruz, José Vázquez‐Prado · 2014 · Biochemical and Biophysical Research Communications
  69. Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers
    Ruth Nussinov, Mingzhen Zhang, Chung‐Jung Tsai, Hyunbum Jang · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  70. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase
    Grace L. Waddell, Emma E. Drew, Henry P. Rupp, Scott D. Hansen · 2023 · Journal of Biological Chemistry
  71. Constructing de Novo H2O2 Signaling via Induced Protein Proximity
    Guihua Zeng, Roushu Zhang, Weimin Xuan, Wei Wang, Fu‐Sen Liang · 2015 · ACS Chemical Biology
  72. Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent.
    S. Arcucci, Fernanda Ramos-Delgado, C. Cayron, N. Therville, M. Gratacap, C. Basset, B. Thibault, J. Guillermet-Guibert · 2021 · Biochemical Journal
  73. Insulin activation of vacuolar protein sorting 34 mediates localized phosphatidylinositol 3-phosphate production at lamellipodia and activation of mTOR/S6K1
    Dianne Snow Hirsch, Yi Shen, Milos Dokmanovic, Joyce E. Yu, Nishant Mohan, M. Khair ElZarrad, Wen Jin Wu · 2014 · Cellular Signalling
  74. Targeting PI3K in cancer treatment: A comprehensive review with insights from clinical outcomes
    Md. Takdir Hossain, Md. Arafat Hossain · 2025 · European Journal of Pharmacology
  75. Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance
    Monika Pliszka, Leszek Szablewski · 2026 · International Journal of Molecular Sciences
  76. Transcriptomic profiling of peripheral blood CD4+ T-cells in asthmatics with and without depression
    Ting Wang, Yulin Ji, Yinyin Yang, Xingyu Xiong, I‐Ming Wang, Andrew J. Sandford, Zong-An Liang, Jian‐Qing He · 2015 · Gene
  77. Galactose‐NlGr11 inhibits AMPK phosphorylation by activating the PI3K‐AKT‐PKF‐ATP signaling cascade via insulin receptor and Gβγ
    Weiwen Chen, Kui Kang, Jun Lv, Lei Yue, Wenqing Zhang · 2020 · Insect Science
  78. The biology behind PI3K inhibition in chronic lymphocytic leukaemia
    Valentín Ortiz‐Maldonado, Marcial García-Morillo, Julio Delgado · 2014 · Therapeutic Advances in Hematology
  79. Characterization of the Phospho-Adhesome by Mass Spectrometry-Based Proteomics
    Joseph M. Robertson, Jonathan D. Humphries, Nikki R. Paul, Stacey Warwood, David Knight, Adam Byron, Martin James Humphries · 2017 · Methods in molecular biology
  80. Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity
    Aliaksei Shymanets, Prajwal Prajwal, Oscar Vadas, Cornelia Czupalla, Jaclyn LoPiccolo, Michael D. Brenowitz, Alessandra Ghigo, Emilio Hirsch, Eberhard Krause, Reinhard Wetzker et al. · 2015 · Biochemical Journal
  81. Methods to Measure the Enzymatic Activity of PI3Ks
    Elisa Ciraolo, Federico Gulluni, Emilio Hirsch · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
  82. Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights
    Md Jamil Hossain, Md. Arafat Hossain · 2025 · Drug Development Research
  83. The orchestrated signaling by PI3Kα and PTEN at the membrane interface
    Danai Maria Kotzampasi, Kyriaki Premeti, Alexandra Papafotika, Vasiliki Syropoulou, Savvas Christoforidis, Zoe Cournia, George Leondaritis · 2022 · Computational and Structural Biotechnology Journal
  84. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway
    Feng Gao, Sichen Liu, Jing Wang, Gang Wei, Chunlei Yu, Lihua Zheng, Luguo Sun, Guannan Wang, Ying Sun, Yongli Bao et al. · 2024 · Journal of Experimental & Clinical Cancer Research
  85. CRISPR–Cas‐Mediated Chemical Control of Transcriptional Dynamics in Yeast
    Daniel Cunningham‐Bryant, Jingwen Sun, Brianna Fernandez, Jesse G. Zalatan · 2019 · ChemBioChem
  86. Single-molecule studies reveal regulatory interactions between master kinases PDK1, AKT1, and PKC
    Moshe T. Gordon, Brian P. Ziemba, Joseph J. Falke · 2021 · Biophysical Journal
  87. Tripeptide SQL Inhibits Platelet Aggregation and Thrombus Formation by Affecting PI3K/Akt Signaling
    Xing-li Su, Wen Su, Zhi-long He, Xin Ming, Yi Kong · 2015 · Journal of Cardiovascular Pharmacology
  88. Structural basis for decreased induction of class IB PI 3‐kinases expression by MIF inhibitors
    Abhay Kumar Singh, Georgios Pantouris, Sebastian Borosch, Siripong Rojanasthien, Thomas Yoonsang Cho · 2016 · Journal of Cellular and Molecular Medicine
  89. Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer
    Abdulhadi H. Jfri, Rachel Meltzer, Arash Mostaghimi, Nicole R. LeBoeuf, Lauren M. Guggina · 2022 · JAMA Oncology
  90. DW09849, a Selective Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Prevents PI3K Signaling and Preferentially Inhibits Proliferation of Cells Containing the Oncogenic Mutation p110α (H1047R)
    Jia-li Liu, Guorui Gao, Xi Zhang, Sufen Cao, Chen-liang Guo, Xiang Wang, Linjiang Tong, Jian Ding, Wenhu Duan, Linghua Meng · 2013 · Journal of Pharmacology and Experimental Therapeutics
  91. Targeting the Protein–Protein Interaction between IRS1 and Mutant p110α for Cancer Therapy
    Yujun Hao, Shuliang Zhao, Zhenghe Wang · 2013 · Toxicologic Pathology
  92. PI3K Isoform-Selective Inhibitors in Cancer
    Leslie Duncan, Chloe Shay, Yong Teng · 2020 · Advances in experimental medicine and biology
  93. Effects of Acute Muscle Contraction on the Key Molecules in Insulin and Akt Signaling in Skeletal Muscle in Health and in Insulin Resistant States
    Gagandeep Mann, Michael Charles Riddell, Olasunkanmi A. J. Adegoke · 2022 · Diabetology
  94. Oncogenic PIK3CA corrupts growth factor signaling specificity
    Ralitsa Radostinova Madsen, Alix Le Marois, Oliwia N Mruk, Margaritis Voliotis, Shaozhen Yin, Jahangir Sufi, Xiao Qin, Salome Jingchen Zhao, Julia Górczyńska, Daniele Morelli et al. · 2024 · Molecular Systems Biology
  95. Targeting the PI3K/AKT/mTOR Pathway in Cancer Cells
    Isabella dos Santos Guimarães, Nayara Gusmão Tessarollo, Paulo Cilas Morais Lyra Junior, Diandra Zipinotti dos Santos, Roger C. Zampier, Laura F.R.L. de Oliveira, Krislayne V. Siqueira, Ian Victor Silva, Letícia Batista Azevedo Rangel · 2015 · InTech eBooks
  96. The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer
    Hong Jun Kim, Suk‐young Lee, Sang Cheul Oh · 2016 · Frontiers in Physiology
  97. Experimental design and model reduction in systems biology
    Jenny E. Jeong, Qinwei Kim-Wee Zhuang, Mark K. Transtrum, Enlu Zhou, Peng Qiu · 2018 · Quantitative Biology
  98. Free energy landscape of the PI3Kα C-terminal activation
    Danai Maria Kotzampasi, Michail Papadourakis, John E. Burke, Zoe Cournia · 2024 · Computational and Structural Biotechnology Journal
  99. Structure, function and inhibition of the phosphoinositide 3-kinase p110α enzyme
    Jack U. Flanagan, Peter Robin Shepherd · 2014 · Biochemical Society Transactions
  100. The GTP responsiveness of PI5P4Kβ evolved from a compromised trade-off between activity and specificity
    Koh Takeuchi, Yoshiki Ikeda, Miki Senda, Ayaka Harada, Koji Okuwaki, Kaori Fukuzawa, So Nakagawa, Hong Yang Yu, Lisa Nagase, Misaki Imai et al. · 2022 · Structure